Investor Overview

We are a science-based company engaged in the identification, research, development, manufacture and distribution of an advanced nutraceutical dietary supplement, Protandim®, and an anti-aging skin care product, LifeVantage TrueScience®, to meet important health and wellness needs. We are focusing our ongoing research efforts on oxidative stress solutions, particularly the activation of Nuclear factor (erythroid-derived 2)-like 2, also known as Nrf2, as it relates to cardiovascular, central nervous system, inflammatory and metabolic diseases, and other health related disorders.

We pursue our mission of “helping people reach their health and wellness goals through science-based solutions to oxidative stress” by providing quality products and a financially rewarding business opportunity to customers and distributors who seek a healthy lifestyle. We sell our products in the United States, Japan, Mexico and Canada, through a network of independent distributors, preferred customers and direct customers. We target our products to several growing market segments:

  • the Nrf2 Activator market;
  • the oxidative stress market;
  • the anti-aging market, for consumers who purchase cosmetics and dietary supplements; and
  • the market of independent distributors seeking to build new businesses and generate income.


Recent Releases

Jan 17, 2012
LifeVantage Expands Board of Directors and Announces Approval of Tender Offer to Modify Warrants

Jan 4, 2012
LifeVantage to Present at 14th Annual ICR XChange

View all releases »

Investor Contacts

Cindy England
(801) 432-9036
investor@lifevantage.com

John Mills
ICR, Inc.
(310) 954-1105